1. Global Markets For Insulin – United States, United Kingdom,
China, India, Germany, Canada, Japan, Australia, Russia, Spain,
Argentina, Armenia, Austria, Azerbaijan, Bangladesh, Belgium,
Bolivia, Bulgaria, Chile, Colombia, Czech Republic, Denmark,
Ecuador, Egypt, Eritrea, Estonia, Ethiopia, Finland, France,
Georgia, Ghana, Greece, Hungary, Indonesia, Iran, Ireland, Italy,
Jordan, Kazakhstan, Kyrgyzstan, Latvia, Lebanon, Lithuania,
Macedonia, Malaysia, Mexico, Moldova, Mongolia, Morocco,
Nepal, Netherlands, Nigeria, Norway, Oman, Pakistan, Panama,
Peru, Philippines, Poland, Portugal, Romania, Senegal, Singapore,
Slovakia, Slovenia, South Africa, South Korea, Sri Lanka, Sudan,
Sweden, Thailand, Turkey, Ukraine, Uruguay, Vietnam
Today, Global Research & Data Services is pleased to announce the publishing of our most recent
set of data and market analyses for the insulin markets across many different countries around
the world. These market research reports offer an in-depth perspective on the actual market
situation, trends and future outlook for insulin in different countries around the world.
The market analyses are available from the following countries:
Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Bulgaria, Canada,
Chile, China, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Eritrea, Estonia, Ethiopia,
Finland, France, Georgia, Germany, Ghana, Greece, Hungary, India, Indonesia, Iran, Ireland, Italy,
Japan, Jordan, Kazakhstan, Kyrgyzstan, Latvia, Lebanon, Lithuania, Macedonia, Malaysia, Mexico,
Moldova, Mongolia, Morocco, Nepal, Netherlands, Nigeria, Norway, Oman, Pakistan, Panama,
Peru, Philippines, Poland, Portugal, Romania, Russia, Senegal, Singapore, Slovakia, Slovenia, South
Africa, South Korea, Spain, Sri Lanka, Sudan, Sweden, Thailand, Turkey, Ukraine, United Kingdom,
United States, Uruguay, Vietnam
The analyses provide essential market information for decision-makers including:
- Overall market value for insulin
- Overall market volume for insulin
- Market value and volume for insulin by type (bulk, dosage)
- Product prices

2. - Forecasts and future outlook for the market
- Country overview, macroeconomic indicators and indicators for doing business
These market analyses answer such important questions such as:
- What is the size of the insulin market?
- How is the market divided into different types of products? Which products are growing fast?
- How has the market been developing? How does the future look like?
- What is the potential for the market?
- How do the indicators for doing business look like? For example, how easily are contracts being
enforced? What is the inflation rate and how is it developing?
You can find more detailed information about the market analyses from our website
http://www.globalresearch.fi/Ready-Market-Analyses/Pharmaceuticals/Insulin/Insulin-
Markets-in-Different-Countries/
These market reports are now available to you at 490 EUR / country. When you order two or
more, you are entitled to get a 15% discount. The analyses are currently available in English in PDF
format and they are delivered by e-mail.
Order now or ask for more information by contacting:
Kimmo Kuokkanen
Product Group Manager
kimmo.kuokkanen@globalresearch.fi
Tel. +358 440 543 230
You can also contact some of our international offices:
USA
usa@globalresearch.fi
Germany
+49 2821 768900
germany@globalresearch.fi
UK
+44 20 7060 7474
uk@globalresearch.fi

3. Sweden
+46 8 5701 0022
sweden@globalresearch.fi
Russia
russia@globalresearch.fi
Ireland
+353 4100 695
ireland@globalresearch.fi
Finland
+358 3 811 4475
finland@globalresearch.fi
China
+86 21 50592442
china@globalresearch.fi
India
+91 22 2757 8668 / 2757 9438
india@globalresearch.fi
Malaysia
+60 7 2387994/ 2385614
malaysia@globalresearch.fi
Singapore
+65 81001564
singapore@globalresearch.fi
Taiwan
+886 2 2799 3110
taiwan@globalresearch.fi
South Korea
+82 2 561 1910
south-korea@globalresearch.fi
Global Research & Data Services constantly studies and writes new market analyses on interesting
and fast developing markets.
Some of our reference customers are: Algol Chemicals, BD (Becton, Dickinson and Company),
Enterprise Ireland / Commercial Section Embassy of Ireland, EPSI Research Services (Svenskt
Kvalitetsindex) , Kemira Oyj, Kingspan Insulation, Kährs Finland Oy, LIEBHERR-RUSSLAND OOO,
MAQUET LLC Russia, Nordkalk Oyj Abp, Paroc Oy Ab, QPR Software Plc, Saint-Gobain Rigips GmbH,

4. Solteq Oyj, STERIS Finn-Aqua, Tamro Oyj, Finnish Healthcare Technology Association, Tikkurila Oyj,
Xella Baustoffe GmbH, AS Fenestra, Bilfinger Berger Industrial Services AG Division Central Europe,
Biohit Oyj, Dometic AB, Eka Chemicals Oy, Envac Scandinavia AB, EnviroChemie GmbH, ENWA
Deutschland Wasseraufbereitung, Karelia-Upofloor Oy, Karwendel-Werke Huber GmbH & Co. KG,
Kuopio Innovation Oy, Kåkå AB, Lepu Medical Technology (Beijing) Co., Ltd, Malco Products, Inc,
Miktech Oy, Mondomed NV, Nitec Pharma AG, Onninen Oy, Preseco Oy, PRÜM-Türenwerk GmbH,
Sachtleben Wasserchemie GmbH, Serres OY, Spirit Store Oy, Tsurumi (Europe) GmbH, Vivoxid Ltd.
and Wipak Oy.
Our customers come from the following countries: UK, USA, Spain, France, Italy, Germany, China,
Sweden, Norway, Netherlands, Austria, Belgium, Switzerland, Czech Republic, Serbia, Finland,
Canada, Australia, Brazil, Hungary, Iran, Latvia, Lithuania, Singapore, Slovakia, Russia, Ukraine,
Portugal, Denmark, Ireland, South Korea, India, Malaysia, Romania, Puerto Rico, Turkey, Croatia,
Lebanon, Estonia and Liechtenstein.